Forte Biosciences, Inc. (FBRX) Stock Price & Growth Analysis - Tweevest

New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out

Forte Biosciences, Inc.

FBRX

NASDAQ

Unprofitable

Unprofitable

52M

Biotechnology

Next Earning date - 24 Mar 2025

52M

Biotechnology

Next Earning date - 24 Mar 2025

8.17USD

0.63 ( 8.36%)

Market Closed (as of Mar 21, 20:00 EDT)

Relative Strenght

6

Volume Buzz

168%

Earning Acce

No

Dist 52w H.

72%

Quote Panel

Updated March 23, 2025

1W 48.01 % 1M -15.34 % 3M -58.53 % 1Y -53.97 %

Key Metrics

Market Cap
52.23M
Shares Outstanding
6.39M
Share in Float
5.17M
Dividende
0

Earning Date
24 Mar 2025
Price Target
8.17
Average Volume
39989
Beta
2.875

Range
4.11-28.68
Industry
Biotechnology
Website
https://www.fortebiorx.com
Sector
Healthcare

Fundamentals

Relative Strength

FBRX

Sector

loading...

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q4.22

N/A

-6.00
vs -5.25

Q1.23

N/A

-8.00
vs -4.25

Q2.23

N/A

-10.50
vs -5.25

Q3.23

N/A

-6.50
vs -4.50

Q4.23

N/A

-1.00
vs -6.00

Q1.24

N/A

-4.00
vs -8.00

Q2.24

N/A

-6.75
vs -10.50

Q3.24

N/A

-4.54
vs -6.50

Q4.24

N/A

-1.99
vs -1.00

Q1.25

N/A

-0.86
vs -4.00

Sales Growth

YoY

Current

Estimates

Q2.22

NA

NA vs NA

Q3.22

NA

NA vs NA

Q4.22

NA

NA vs NA

Q1.23

NA

NA vs NA

Q2.23

NA

NA vs NA

Q3.23

NA

NA vs NA

Q4.23

NA

6K vs NA

Q1.24

NA

NA vs NA

Q2.24

NA

NA vs NA

Q3.24

NA

NA vs NA

Return on Equity

QoQ

Q4.22

-13%

-0.13
vs -0.08

Q1.23

-20%

-0.20
vs -0.13

Q2.23

-36%

-0.36
vs -0.20

Q3.23

-25%

-0.25
vs -0.36

Q4.23

-17%

-0.17
vs -0.25

Q1.24

-26%

-0.26
vs -0.17

Q2.24

-74%

-0.74
vs -0.26

Q3.24

-90%

-0.90
vs -0.74

Institutionnal Ownership

QoQ

Q3.22

26

26
vs 32

-19%

Q4.22

33

33
vs 26

27%

Q1.23

30

30
vs 33

-9%

Q2.23

31

31
vs 30

3%

Q3.23

32

32
vs 31

3%

Q4.23

36

36
vs 32

13%

Q1.24

33

33
vs 36

-8%

Q2.24

34

34
vs 33

3%

Earnings Growth

Latest News

FBRX

zacks.com

9 hours ago

Here's Why Momentum in Forte Biosciences (FBRX) Should Keep going

FBRX

businesswire.com

9 hours ago

Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications

FBRX

zacks.com

10 hours ago

Forte Biosciences (FBRX) Is a Great Choice for 'Trend' Investors, Here's Why

FBRX

zacks.com

13 hours ago

Forte Biosciences (FBRX) Upgraded to Buy: What Does It Mean for the Stock?

FBRX

businesswire.com

16 hours ago

Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules

FBRX

businesswire.com

16 hours ago

Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update